SBIR/STTR Research Award
Hypoxia-Perfusion Bioreactor for Stem Cell Applications
Award amount
$155,134Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RESODYN CORP
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NUT8PKD37ZH3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Cord blood (CB) cells are a desirable source of stem cells for transplantation because their collection poses no donor impact and they would facilitate the creation of an ethnically diverse pool of donor cells. However
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Resonant Acoustic Continuous Crystallizer for Safe and Tunable Recrystallization of Nitramines
- Continuous Synthesis of High-Value Critical Defense Materials with Continuous Acoustic Reactor System
- Alternative Mixing Technologies for High-Energy, Solid Materials for Large Gas Generator Propellant
- Resonant Acoustic Continuous Crystallizer for Safe and Tunable Recrystallization of Nitramines
- External Drum Dynamometer Runway Texture Coating
Research funding history
120 SBIR/STTR records share this UEI (1993–2023). Reported award amounts total $31,803,873. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Science Foundation, Department of Health and Human Services, Department of Energy, Environmental Protection Agency, Department of Agriculture